ÂÜÀòÂÒÂ×

Piers Jamie Ingram has served as the Chief Executive Officer and as a member of the board of directors since co-founding Hummingbird Bioscience in 2015. Between 2013 and 2015 Dr. Ingram was employed by Sanofi (NASDAQ: SNY) as Head of Strategic Planning, South East Asia, and between 2011 and 2013 at Monitor Group (and then Monitor Deloitte) as a Manager in the Strategy Consulting practice. Between 2008 and 2010, Dr. Ingram was first a Research Fellow and then acting Research Group Head at the Centre for Integrative Systems Biology, Imperial College London. Dr. Ingram holds an MSci in Mathematics, an MSc in Bioinformatics and a PhD in Systems Biology from Imperial College London, and an MBA from INSEAD.